ResearcherDartmouth CollegeNo recent work listed

Radu Virgil Stan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2969-1725; OpenAlex author ID A5026125920; NIH RePORTER profile ID 2245934. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 grant

Papers 1

PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. Last author DOI 10.1111/j.1582-4934.2012.01587.x ↗

Grants 1

Anti-PV1 Therapy for Pancreatic Cancer R21CA172983 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Catherine Carrière · 1 shared paper, 1 shared grant, 2012–2014 · strength 0.21
- Grant Anti-PV1 Therapy for Pancreatic Cancer R21CA172983 ↗
- Paper PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. DOI 10.1111/j.1582-4934.2012.01587.x ↗
Daniel S. Longnecker · 1 shared paper, 2012 · strength 0.03
- Paper PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. DOI 10.1111/j.1582-4934.2012.01587.x ↗
Sophie J. Deharvengt · 1 shared paper, 2012 · strength 0.03
- Paper PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. DOI 10.1111/j.1582-4934.2012.01587.x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.